|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 515 N. STATE STREET, CHICAGO |
State | IL |
Zip Code | 60654 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD, Division of Legislative Counsel |
Date | 07/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions
S. 1734, Generating Antibiotic Incentives Now Act of 2011, all provisions
H.R. 4095, Online Pharmacy Safety Act, all provisions
S. 2002, Online Pharmacy Safety Act, all provisions
H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011, all provisions
S. 296, Preserving Access to Life-Saving Medications Act, all provisions
H.R. 2086, Medical Debt Responsibility Act of 2011, all provisions
S. 2149, Medical Debt Responsibility Act of 2012, all provisions
H.R. 5651, Food and Drug Administration Reform Act of 2012, all provisions
S. 3187, Food and Drug Administration Safety and Innovation Act, all provisions
H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions
S. 2295, Patient Safety and Generic Labeling Improvement Act , all provisions
H.R. 2119, Ryan Creedon Act of 2011, all provisions
H.R. 3497, MODDERN Cures Act of 2011, all provisions
H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions
H.R. 2939, Pharmaceutical Stewardship Act of 2011, all provisions
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions
H.R. 3839, Drug Shortage Prevention Act of 2012, all provisions
H.R. 5842, Restoring Access to Medication Act of 2012, all provisions
S.Amdt. 2151, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug
Mandatory CME for DEA Registrants
Bath Salts
Tanning Beds
Affordable Care Act
Insurance exchanges
Violence Against Women Act, provisions relating to quality
Drug Shortages
Prescription Drug Abuse
Next generation antibiotics
Scope of Practice
Health Insurance Reform
Health Information Technology
Flexible Spending Accounts/OTC medications
Tax deduction for physician charity care
HIPAA Administrative Simplification
HIPAA privacy and security standards
Regulation of energy beverages
Unique Device Identification System
Multi-Payor Claims Database
Private payer guidelines for reporting data to physicians
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 5888, Physician Reentry Demonstration Program Act, all provisions
FTC and Medical Licensing Boards
Health Insurer Mergers
Antitrust
DOJ-FTC Health Care Antitrust Guidelines
Health Care Market Competition
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), Justice - Dept of (DOJ), Centers For Medicare and Medicaid Services (CMS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1700, Medicare Patient Empowerment Act, all provisions
S. 1042, Medicare Patient Empowerment Act, all provisions
H.R. 452, Medicare Decisions Accountability Act of 2011, all provisions
S. 668, Health Care Bureaucrats Elimination Act, all provisions
H.R. 5, Protecting Access to Healthcare Act, provision relating to IPAB repeal
H.R. 5942, Quality Improvement Organization Program Restoration Act, all provisions
H.R. 5707, Medicare Physician Payment Innovation Act of 2012, all provisions
Medicare program - Private Contracting
Medicare program - Sustainable Growth Rate (SGR)
Medicare program - Physician Payment Update
Medicare program - Power mobility devices
Medicare program - Quality Resource Use Reports
Medicare program - Hospital Acquired Conditions
Medicare program - eRx penalty program
Medicare program - EHR Incentive Program
Medicare program - Primary care bonus program
Medicare program - ICD-10
Medicare program - Medicare Economic Index
Medicare program - Value-based Modifier
Medicare program - Confidential Feedback Reports
Medicare program - Codes for Molecular Pathology
Medicare program - Bundled payments
Medicare program - Care Coordination
Medicare program - Observation Care
Medicare program - Penalties
Medicare program - Place of service coding and 3-day payment window
Medicare program - RAC prepayment demonstrations
Medicare program - Payment and delivery reform
Medicare program - Hospital outpatient payments
Medicare program - MedPAC Nominations
Medicare program - Graduate Medical Education
Medicare program - Health Information Technology
Medicare program - Enrollment
Medicare program - Physician Consortium for Performance Improvement
Medicare program - DME audits/supplier requests for documentation
Medicare program - Alternative payment models
Medicare program - Guidelines for reporting data to physicians
Medicare program - AMA quality measure copyright
Medicare program - Physician Compare and PECOS
Medicare program - Resource-based Relative Value Scale/RVS Update Committee
Medicare program - Shared Savings/Accountable Care Organizations
Medicare and Medicaid programs - HIPAA Administrative Simplification
Medicare and Medicaid programs - Conditions of Participation
Medicare and Medicaid programs - Meaningful Use
Medicare and Medicaid programs - Center for Medicare and Medicaid Innovation initiatives
Medicare and medicaid programs - Program Integrity
Medicaid program - Dual Eligibles
Medicaid program - Primary care payments
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 816, Provider Shield Act of 2011, all provisions
H.R. 3586, Good Samaritan Health Professionals Act of 2011, all provisions
H.R. 5, Protecting Access to Healthcare Act, all provisions
H.R. 5888, Physician Reentry Demonstration Program Act, provisions relating to liability
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
FY 2013 National Defense Authorization Act, provisions requiring Medicare participating physicians to also participate in TRICARE
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Kathleen |
Tenoever |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Sharon |
McIlrath |
|
|
|
Mari |
Savickis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco policy
FDA tobacco oversight authority
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2013 Appropriations, Funding for EPA's Environmental Justice Programs
FY 2013 Labor-HHS Appropriations, Preventive Health and Health Services Block Grant Program funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TAX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |